MyFinsight
Home
Blog
About
Back
Income Statement
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)
source: myfinsight.com
Net loss
attributable to rani...
-$7,391,000
(-10.45%↓ Y/Y)
Net gain
attributable to...
-$1,030,000
(77.27%↑ Y/Y)
Net loss
-$8,421,000
(24.97%↑ Y/Y)
Interest income and
other, net
$415,000
(162.66%↑ Y/Y)
Loss from operations
-$8,828,000
(15.96%↑ Y/Y)
Contract revenue
$1,708,000
Interest expense and
other, net
$8,000
(-99.09%↓ Y/Y)
Total operating
expenses
$10,536,000
(0.30%↑ Y/Y)
General and
administrative
$5,519,000
(10.38%↑ Y/Y)
Research and development
$5,017,000
(-8.86%↓ Y/Y)
Back